Jenscare Scientific Co., Ltd. (SEHK: 9877)
Health Care · Health Care Equipment & Supplies · CN
HK$7.10
-3.99% today · -32.8% 1Y
Jenscare Scientific Co., Ltd. (SEHK: 9877) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $377.37M and employs 225 people.
Over the last twelve months the share price has lost 32.8%, trading between 6.00 and 11.98.
Tweenvest scores Jenscare Scientific Co., Ltd. across four factors: quality 44/100, value 66/100. Its strongest factor is value.
9877 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $377.37M
- Revenue (TTM)
- $20.80M
- P/E
- —
- EPS
- -0.35
- Dividend yield
- —
- Beta (5Y)
- 0.61
- 52-week high
- HK$11.98
- 52-week low
- HK$6.00
- Avg volume (3M)
- —
- Shares outstanding
- 417.10M
- Employees
- 225
- Next earnings
- —
About Jenscare Scientific Co., Ltd.
Jenscare Scientific Co., Ltd. operates as a medical technology enterprise dedicated to advancing interventional therapies for structural heart conditions within the People's Republic of China. Among its pipeline, the company features LuX-Valve, an investigational transcatheter tricuspid valve replacement (TTVR) system designed for patients suffering from severe tricuspid regurgitation who face elevated surgical risks. Additionally, Ken-Valve represents another key product candidate, a transcatheter aortic valve replacement (TAVR) aimed at addressing severe aortic regurgitation, often co-occurring with aortic stenosis. The applications of Jenscare's portfolio extend to a range of structural cardiac maladies, including disorders of the tricuspid, aortic, and mitral valves, as well as heart failure. Founded in 2011, the company maintains its principal place of business in Ningbo, People's Republic of China.
- ISIN
- CNE100005KC9
- Founded
- 2011
- Listed since
- Oct 10, 2022
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| CellaVision AB (publ)OM: CEVI | $385.95M | Skr161.80 | -2.06% |
| Jiangsu Apon Medical Technology Co., Ltd.SZSE: 300753 | $381.45M | CN¥20.27 | -1.89% |
| Allgens Medical Technology CO., LTD.SHSE: 688613 | $379.85M | CN¥18.57 | -7.61% |
| Shoulder Innovations, Inc.NYSE: SI | $377.45M | $18.13 | -4.63% |
| NIOX Group PlcAIM: NIOX | $376.48M | £0.68 | -0.88% |
| SofWave Medical Ltd.TASE: SOFW | $374.65M | ₪31.62 | -5.33% |
| Orthofix Medical Inc.NasdaqGS: OFIX | $373.52M | $9.17 | +0.88% |
| Vizionfocus Inc.TWSE: 4771 | $372.89M | NT$203.00 | -5.14% |
Figures last refreshed Oct 11, 2026.